Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1875 1
1887 1
1896 1
1903 1
1912 1
1915 2
1916 1
1917 2
1919 2
1920 2
1921 1
1926 1
1927 1
1928 2
1933 1
1934 1
1935 1
1936 2
1937 2
1939 3
1940 1
1941 4
1942 1
1943 1
1944 2
1945 36
1946 140
1947 129
1948 152
1949 129
1950 172
1951 235
1952 331
1953 418
1954 373
1955 419
1956 425
1957 403
1958 398
1959 329
1960 242
1961 305
1962 287
1963 296
1964 608
1965 665
1966 626
1967 850
1968 1126
1969 1080
1970 1073
1971 1091
1972 1106
1973 1186
1974 1319
1975 1312
1976 1318
1977 1362
1978 1398
1979 1428
1980 1348
1981 1402
1982 1420
1983 1604
1984 1692
1985 1897
1986 1840
1987 1846
1988 1968
1989 2196
1990 2348
1991 2401
1992 2456
1993 2574
1994 2563
1995 2591
1996 2967
1997 3084
1998 3231
1999 3464
2000 3674
2001 3906
2002 4287
2003 4706
2004 5088
2005 5518
2006 6198
2007 6550
2008 6832
2009 7245
2010 7707
2011 8190
2012 8895
2013 9646
2014 10702
2015 11438
2016 12482
2017 13361
2018 14411
2019 15898
2020 18973
2021 20367
2022 18994
2023 17617
2024 6411

Text availability

Article attribute

Article type

Publication date

Search Results

289,361 results

Results by year

Filters applied: . Clear all
Page 1
Screening for Colorectal Cancer.
Gupta S. Gupta S. Hematol Oncol Clin North Am. 2022 Jun;36(3):393-414. doi: 10.1016/j.hoc.2022.02.001. Epub 2022 Apr 30. Hematol Oncol Clin North Am. 2022. PMID: 35501176 Free PMC article. Review.
Colorectal cancer (CRC) is the second-leading cause of cancer death in the United States. ...USPSTF guidelines recommend annual guaiac fecal occult blood testing, annual fecal immunochemical testing (FIT), annual to every 3-year multitarg …
Colorectal cancer (CRC) is the second-leading cause of cancer death in the United States. ...USPSTF guidelines recommend annua …
Strategies for Colorectal Cancer Screening.
Ladabaum U, Dominitz JA, Kahi C, Schoen RE. Ladabaum U, et al. Gastroenterology. 2020 Jan;158(2):418-432. doi: 10.1053/j.gastro.2019.06.043. Epub 2019 Aug 5. Gastroenterology. 2020. PMID: 31394083 Free article. Review.
Screening methods are effective but have limitations. Furthermore, many screen-eligible people remain unscreened. We discuss established and emerging screening methods, and potential strategies to address current limitations in CRC screening …
Screening methods are effective but have limitations. Furthermore, many screen-eligible people remain unscreened. We di …
Multitarget Stool RNA Test for Colorectal Cancer Screening.
Barnell EK, Wurtzler EM, La Rocca J, Fitzgerald T, Petrone J, Hao Y, Kang Y, Holmes FL, Lieberman DA. Barnell EK, et al. JAMA. 2023 Nov 14;330(18):1760-1768. doi: 10.1001/jama.2023.22231. JAMA. 2023. PMID: 37870871 Free PMC article. Clinical Trial.
IMPORTANCE: Noninvasive tests for colorectal cancer screening must include sensitive detection of colorectal cancer and precancerous lesions. ...Of the 8920 eligible participants, 36 (0.40%) had colorectal cancer and 606 (6.8%) had advanced aden …
IMPORTANCE: Noninvasive tests for colorectal cancer screening must include sensitive detection of colorectal cancer …
Use of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis.
Lee MW, Pourmorady JS, Laine L. Lee MW, et al. Am J Gastroenterol. 2020 May;115(5):662-670. doi: 10.14309/ajg.0000000000000495. Am J Gastroenterol. 2020. PMID: 31972617
INTRODUCTION: Fecal occult blood tests (FOBTs) are validated only for colorectal cancer (CRC) screening, but are commonly used as a diagnostic test in other clinical settings. We performed a systematic review to assess performance characteristic …
INTRODUCTION: Fecal occult blood tests (FOBTs) are validated only for colorectal cancer (CRC) screening, …
Multitarget stool DNA testing for colorectal-cancer screening.
Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM. Imperiale TF, et al. N Engl J Med. 2014 Apr 3;370(14):1287-97. doi: 10.1056/NEJMoa1311194. Epub 2014 Mar 19. N Engl J Med. 2014. PMID: 24645800 Free article. Clinical Trial.
BACKGROUND: An accurate, noninvasive test could improve the effectiveness of colorectal-cancer screening. METHODS: We compared a noninvasive, multitarget stool DNA test with a fecal immunochemical test (FIT) in persons at average risk for colorectal …
BACKGROUND: An accurate, noninvasive test could improve the effectiveness of colorectal-cancer screening. METHODS: We c …
Colorectal cancer screening: An updated review of the available options.
Issa IA, Noureddine M. Issa IA, et al. World J Gastroenterol. 2017 Jul 28;23(28):5086-5096. doi: 10.3748/wjg.v23.i28.5086. World J Gastroenterol. 2017. PMID: 28811705 Free PMC article. Review.
However, colon cancer incidence and mortality is declining over the past decade owing to adoption of effective screening programs. ...Hence, leading to increase in colon cancer detection and prevention. This article will discuss various CRC screenin …
However, colon cancer incidence and mortality is declining over the past decade owing to adoption of effective screening progr …
Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis.
Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Lee JK, et al. Ann Intern Med. 2014 Feb 4;160(3):171. doi: 10.7326/M13-1484. Ann Intern Med. 2014. PMID: 24658694 Free PMC article. Review.
BACKGROUND: Performance characteristics of fecal immunochemical tests (FITs) to screen for colorectal cancer (CRC) have been inconsistent. ...PRIMARY FUNDING SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases and National Cance …
BACKGROUND: Performance characteristics of fecal immunochemical tests (FITs) to screen for colorectal cancer (CRC) have …
Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.
Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ, Etzioni R, McKenna MT, Oeffinger KC, Shih YT, Walter LC, Andrews KS, Brawley OW, Brooks D, Fedewa SA, Manassaram-Baptiste D, Siegel RL, Wender RC, Smith RA. Wolf AMD, et al. CA Cancer J Clin. 2018 Jul;68(4):250-281. doi: 10.3322/caac.21457. Epub 2018 May 30. CA Cancer J Clin. 2018. PMID: 29846947 Free article.
Screening with any one of multiple options is associated with a significant reduction in CRC incidence through the detection and removal of adenomatous polyps and other precancerous lesions and with a reduction in mortality through incidence reduction and early …
Screening with any one of multiple options is associated with a significant reduction in CRC incidence through the detection a …
Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C).
Chen H, Shi J, Lu M, Li Y, Du L, Liao X, Wei D, Dong D, Gao Y, Zhu C, Ying R, Zheng W, Yan S, Xiao H, Zhang J, Kong Y, Li F, Zou S, Liu C, Wang H, Zhang Y, Lu B, Luo C, Cai J, Tian J, Miao X, Ding K, Brenner H, Dai M. Chen H, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):808-818. doi: 10.1016/j.cgh.2022.08.003. Epub 2022 Aug 11. Clin Gastroenterol Hepatol. 2023. PMID: 35964896 Free article. Clinical Trial.
BACKGROUND & AIMS: The screening yield and related cost of a risk-adapted screening approach compared with established screening strategies in population-based colorectal cancer (CRC) screening are not clear. METHODS: We randomly allo …
BACKGROUND & AIMS: The screening yield and related cost of a risk-adapted screening approach compared with established …
Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial.
Randel KR, Schult AL, Botteri E, Hoff G, Bretthauer M, Ursin G, Natvig E, Berstad P, Jørgensen A, Sandvei PK, Olsen ME, Frigstad SO, Darre-Næss O, Norvard ER, Bolstad N, Kørner H, Wibe A, Wensaas KA, de Lange T, Holme Ø. Randel KR, et al. Gastroenterology. 2021 Mar;160(4):1085-1096.e5. doi: 10.1053/j.gastro.2020.11.037. Epub 2020 Nov 21. Gastroenterology. 2021. PMID: 33227280 Free article. Clinical Trial.
BACKGROUND & AIMS: The comparative effectiveness of sigmoidoscopy and fecal immunochemical testing (FIT) for colorectal cancer (CRC) screening is unknown. METHODS: Individuals aged 50-74 years living in Southeast Norway were randomly invited betwee …
BACKGROUND & AIMS: The comparative effectiveness of sigmoidoscopy and fecal immunochemical testing (FIT) for colorectal cancer …
289,361 results
You have reached the last available page of results. Please see the User Guide for more information.